Global CGT Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for CGT Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CGT Drugs players cover Janssen Biotech, Celgene Corporation, Juno Therapeutics, Kite Pharma and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CGT Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CGT Drugs market, with both quantitative and qualitative data, to help readers understand how the CGT Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the CGT Drugs market and forecasts the market size by Type (CAR-T Therapy, Viral Vector Therapy and Stem Cell Therapy), by Application (Rare Disease, Tumor Disease, Eye Disease and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of CGT Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global CGT Drugs market size (sales and revenue) and CAGR, CGT Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CGT Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CGT Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CGT Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Janssen Biotech, Celgene Corporation, Juno Therapeutics, Kite Pharma, Novartis, Spark Therapeutics, Amgen, Bluebird Bio and GSK, etc.
Chapter 14: Research Findings and Conclusion
The global market for CGT Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CGT Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CGT Drugs players cover Janssen Biotech, Celgene Corporation, Juno Therapeutics, Kite Pharma and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CGT Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CGT Drugs market, with both quantitative and qualitative data, to help readers understand how the CGT Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the CGT Drugs market and forecasts the market size by Type (CAR-T Therapy, Viral Vector Therapy and Stem Cell Therapy), by Application (Rare Disease, Tumor Disease, Eye Disease and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- CAR-T Therapy
- Viral Vector Therapy
- Stem Cell Therapy
- Oncolytic Virus Therapy
- Rare Disease
- Tumor Disease
- Eye Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Janssen Biotech
- Celgene Corporation
- Juno Therapeutics
- Kite Pharma
- Novartis
- Spark Therapeutics
- Amgen
- Bluebird Bio
- GSK
- Orchard Therapeutics
- Sequoia
- Fosun Kite Biotechnology
- Sunway Biotech
- SiBiono
Chapter 1: Scope of CGT Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global CGT Drugs market size (sales and revenue) and CAGR, CGT Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CGT Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CGT Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CGT Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Janssen Biotech, Celgene Corporation, Juno Therapeutics, Kite Pharma, Novartis, Spark Therapeutics, Amgen, Bluebird Bio and GSK, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CGT Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for CGT Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for CGT Drugs by Country/Region, 2017, 2022 & 2028
2.2 CGT Drugs Segment by Type
2.2.1 CAR-T Therapy
2.2.2 Viral Vector Therapy
2.2.3 Stem Cell Therapy
2.2.4 Oncolytic Virus Therapy
2.3 CGT Drugs Sales by Type
2.3.1 Global CGT Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global CGT Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global CGT Drugs Sale Price by Type (2017-2022)
2.4 CGT Drugs Segment by Application
2.4.1 Rare Disease
2.4.2 Tumor Disease
2.4.3 Eye Disease
2.4.4 Others
2.5 CGT Drugs Sales by Application
2.5.1 Global CGT Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global CGT Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global CGT Drugs Sale Price by Application (2017-2022)
3 GLOBAL CGT DRUGS BY COMPANY
3.1 Global CGT Drugs Breakdown Data by Company
3.1.1 Global CGT Drugs Annual Sales by Company (2020-2022)
3.1.2 Global CGT Drugs Sales Market Share by Company (2020-2022)
3.2 Global CGT Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global CGT Drugs Revenue by Company (2020-2022)
3.2.2 Global CGT Drugs Revenue Market Share by Company (2020-2022)
3.3 Global CGT Drugs Sale Price by Company
3.4 Key Manufacturers CGT Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CGT Drugs Product Location Distribution
3.4.2 Players CGT Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CGT DRUGS BY GEOGRAPHIC REGION
4.1 World Historic CGT Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global CGT Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global CGT Drugs Annual Revenue by Geographic Region
4.2 World Historic CGT Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global CGT Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global CGT Drugs Annual Revenue by Country/Region
4.3 Americas CGT Drugs Sales Growth
4.4 APAC CGT Drugs Sales Growth
4.5 Europe CGT Drugs Sales Growth
4.6 Middle East & Africa CGT Drugs Sales Growth
5 AMERICAS
5.1 Americas CGT Drugs Sales by Country
5.1.1 Americas CGT Drugs Sales by Country (2017-2022)
5.1.2 Americas CGT Drugs Revenue by Country (2017-2022)
5.2 Americas CGT Drugs Sales by Type
5.3 Americas CGT Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CGT Drugs Sales by Region
6.1.1 APAC CGT Drugs Sales by Region (2017-2022)
6.1.2 APAC CGT Drugs Revenue by Region (2017-2022)
6.2 APAC CGT Drugs Sales by Type
6.3 APAC CGT Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CGT Drugs by Country
7.1.1 Europe CGT Drugs Sales by Country (2017-2022)
7.1.2 Europe CGT Drugs Revenue by Country (2017-2022)
7.2 Europe CGT Drugs Sales by Type
7.3 Europe CGT Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CGT Drugs by Country
8.1.1 Middle East & Africa CGT Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa CGT Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa CGT Drugs Sales by Type
8.3 Middle East & Africa CGT Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CGT Drugs
10.3 Manufacturing Process Analysis of CGT Drugs
10.4 Industry Chain Structure of CGT Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CGT Drugs Distributors
11.3 CGT Drugs Customer
12 WORLD FORECAST REVIEW FOR CGT DRUGS BY GEOGRAPHIC REGION
12.1 Global CGT Drugs Market Size Forecast by Region
12.1.1 Global CGT Drugs Forecast by Region (2023-2028)
12.1.2 Global CGT Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global CGT Drugs Forecast by Type
12.7 Global CGT Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Janssen Biotech
13.1.1 Janssen Biotech Company Information
13.1.2 Janssen Biotech CGT Drugs Product Offered
13.1.3 Janssen Biotech CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Janssen Biotech Main Business Overview
13.1.5 Janssen Biotech Latest Developments
13.2 Celgene Corporation
13.2.1 Celgene Corporation Company Information
13.2.2 Celgene Corporation CGT Drugs Product Offered
13.2.3 Celgene Corporation CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Celgene Corporation Main Business Overview
13.2.5 Celgene Corporation Latest Developments
13.3 Juno Therapeutics
13.3.1 Juno Therapeutics Company Information
13.3.2 Juno Therapeutics CGT Drugs Product Offered
13.3.3 Juno Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Juno Therapeutics Main Business Overview
13.3.5 Juno Therapeutics Latest Developments
13.4 Kite Pharma
13.4.1 Kite Pharma Company Information
13.4.2 Kite Pharma CGT Drugs Product Offered
13.4.3 Kite Pharma CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kite Pharma Main Business Overview
13.4.5 Kite Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis CGT Drugs Product Offered
13.5.3 Novartis CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Spark Therapeutics
13.6.1 Spark Therapeutics Company Information
13.6.2 Spark Therapeutics CGT Drugs Product Offered
13.6.3 Spark Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Spark Therapeutics Main Business Overview
13.6.5 Spark Therapeutics Latest Developments
13.7 Amgen
13.7.1 Amgen Company Information
13.7.2 Amgen CGT Drugs Product Offered
13.7.3 Amgen CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Amgen Main Business Overview
13.7.5 Amgen Latest Developments
13.8 Bluebird Bio
13.8.1 Bluebird Bio Company Information
13.8.2 Bluebird Bio CGT Drugs Product Offered
13.8.3 Bluebird Bio CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bluebird Bio Main Business Overview
13.8.5 Bluebird Bio Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK CGT Drugs Product Offered
13.9.3 GSK CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Orchard Therapeutics
13.10.1 Orchard Therapeutics Company Information
13.10.2 Orchard Therapeutics CGT Drugs Product Offered
13.10.3 Orchard Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Orchard Therapeutics Main Business Overview
13.10.5 Orchard Therapeutics Latest Developments
13.11 Sequoia
13.11.1 Sequoia Company Information
13.11.2 Sequoia CGT Drugs Product Offered
13.11.3 Sequoia CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sequoia Main Business Overview
13.11.5 Sequoia Latest Developments
13.12 Fosun Kite Biotechnology
13.12.1 Fosun Kite Biotechnology Company Information
13.12.2 Fosun Kite Biotechnology CGT Drugs Product Offered
13.12.3 Fosun Kite Biotechnology CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Fosun Kite Biotechnology Main Business Overview
13.12.5 Fosun Kite Biotechnology Latest Developments
13.13 Sunway Biotech
13.13.1 Sunway Biotech Company Information
13.13.2 Sunway Biotech CGT Drugs Product Offered
13.13.3 Sunway Biotech CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Sunway Biotech Main Business Overview
13.13.5 Sunway Biotech Latest Developments
13.14 SiBiono
13.14.1 SiBiono Company Information
13.14.2 SiBiono CGT Drugs Product Offered
13.14.3 SiBiono CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 SiBiono Main Business Overview
13.14.5 SiBiono Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CGT Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for CGT Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for CGT Drugs by Country/Region, 2017, 2022 & 2028
2.2 CGT Drugs Segment by Type
2.2.1 CAR-T Therapy
2.2.2 Viral Vector Therapy
2.2.3 Stem Cell Therapy
2.2.4 Oncolytic Virus Therapy
2.3 CGT Drugs Sales by Type
2.3.1 Global CGT Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global CGT Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global CGT Drugs Sale Price by Type (2017-2022)
2.4 CGT Drugs Segment by Application
2.4.1 Rare Disease
2.4.2 Tumor Disease
2.4.3 Eye Disease
2.4.4 Others
2.5 CGT Drugs Sales by Application
2.5.1 Global CGT Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global CGT Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global CGT Drugs Sale Price by Application (2017-2022)
3 GLOBAL CGT DRUGS BY COMPANY
3.1 Global CGT Drugs Breakdown Data by Company
3.1.1 Global CGT Drugs Annual Sales by Company (2020-2022)
3.1.2 Global CGT Drugs Sales Market Share by Company (2020-2022)
3.2 Global CGT Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global CGT Drugs Revenue by Company (2020-2022)
3.2.2 Global CGT Drugs Revenue Market Share by Company (2020-2022)
3.3 Global CGT Drugs Sale Price by Company
3.4 Key Manufacturers CGT Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CGT Drugs Product Location Distribution
3.4.2 Players CGT Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CGT DRUGS BY GEOGRAPHIC REGION
4.1 World Historic CGT Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global CGT Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global CGT Drugs Annual Revenue by Geographic Region
4.2 World Historic CGT Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global CGT Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global CGT Drugs Annual Revenue by Country/Region
4.3 Americas CGT Drugs Sales Growth
4.4 APAC CGT Drugs Sales Growth
4.5 Europe CGT Drugs Sales Growth
4.6 Middle East & Africa CGT Drugs Sales Growth
5 AMERICAS
5.1 Americas CGT Drugs Sales by Country
5.1.1 Americas CGT Drugs Sales by Country (2017-2022)
5.1.2 Americas CGT Drugs Revenue by Country (2017-2022)
5.2 Americas CGT Drugs Sales by Type
5.3 Americas CGT Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CGT Drugs Sales by Region
6.1.1 APAC CGT Drugs Sales by Region (2017-2022)
6.1.2 APAC CGT Drugs Revenue by Region (2017-2022)
6.2 APAC CGT Drugs Sales by Type
6.3 APAC CGT Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CGT Drugs by Country
7.1.1 Europe CGT Drugs Sales by Country (2017-2022)
7.1.2 Europe CGT Drugs Revenue by Country (2017-2022)
7.2 Europe CGT Drugs Sales by Type
7.3 Europe CGT Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CGT Drugs by Country
8.1.1 Middle East & Africa CGT Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa CGT Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa CGT Drugs Sales by Type
8.3 Middle East & Africa CGT Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CGT Drugs
10.3 Manufacturing Process Analysis of CGT Drugs
10.4 Industry Chain Structure of CGT Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CGT Drugs Distributors
11.3 CGT Drugs Customer
12 WORLD FORECAST REVIEW FOR CGT DRUGS BY GEOGRAPHIC REGION
12.1 Global CGT Drugs Market Size Forecast by Region
12.1.1 Global CGT Drugs Forecast by Region (2023-2028)
12.1.2 Global CGT Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global CGT Drugs Forecast by Type
12.7 Global CGT Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Janssen Biotech
13.1.1 Janssen Biotech Company Information
13.1.2 Janssen Biotech CGT Drugs Product Offered
13.1.3 Janssen Biotech CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Janssen Biotech Main Business Overview
13.1.5 Janssen Biotech Latest Developments
13.2 Celgene Corporation
13.2.1 Celgene Corporation Company Information
13.2.2 Celgene Corporation CGT Drugs Product Offered
13.2.3 Celgene Corporation CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Celgene Corporation Main Business Overview
13.2.5 Celgene Corporation Latest Developments
13.3 Juno Therapeutics
13.3.1 Juno Therapeutics Company Information
13.3.2 Juno Therapeutics CGT Drugs Product Offered
13.3.3 Juno Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Juno Therapeutics Main Business Overview
13.3.5 Juno Therapeutics Latest Developments
13.4 Kite Pharma
13.4.1 Kite Pharma Company Information
13.4.2 Kite Pharma CGT Drugs Product Offered
13.4.3 Kite Pharma CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kite Pharma Main Business Overview
13.4.5 Kite Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis CGT Drugs Product Offered
13.5.3 Novartis CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Spark Therapeutics
13.6.1 Spark Therapeutics Company Information
13.6.2 Spark Therapeutics CGT Drugs Product Offered
13.6.3 Spark Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Spark Therapeutics Main Business Overview
13.6.5 Spark Therapeutics Latest Developments
13.7 Amgen
13.7.1 Amgen Company Information
13.7.2 Amgen CGT Drugs Product Offered
13.7.3 Amgen CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Amgen Main Business Overview
13.7.5 Amgen Latest Developments
13.8 Bluebird Bio
13.8.1 Bluebird Bio Company Information
13.8.2 Bluebird Bio CGT Drugs Product Offered
13.8.3 Bluebird Bio CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bluebird Bio Main Business Overview
13.8.5 Bluebird Bio Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK CGT Drugs Product Offered
13.9.3 GSK CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Orchard Therapeutics
13.10.1 Orchard Therapeutics Company Information
13.10.2 Orchard Therapeutics CGT Drugs Product Offered
13.10.3 Orchard Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Orchard Therapeutics Main Business Overview
13.10.5 Orchard Therapeutics Latest Developments
13.11 Sequoia
13.11.1 Sequoia Company Information
13.11.2 Sequoia CGT Drugs Product Offered
13.11.3 Sequoia CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sequoia Main Business Overview
13.11.5 Sequoia Latest Developments
13.12 Fosun Kite Biotechnology
13.12.1 Fosun Kite Biotechnology Company Information
13.12.2 Fosun Kite Biotechnology CGT Drugs Product Offered
13.12.3 Fosun Kite Biotechnology CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Fosun Kite Biotechnology Main Business Overview
13.12.5 Fosun Kite Biotechnology Latest Developments
13.13 Sunway Biotech
13.13.1 Sunway Biotech Company Information
13.13.2 Sunway Biotech CGT Drugs Product Offered
13.13.3 Sunway Biotech CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Sunway Biotech Main Business Overview
13.13.5 Sunway Biotech Latest Developments
13.14 SiBiono
13.14.1 SiBiono Company Information
13.14.2 SiBiono CGT Drugs Product Offered
13.14.3 SiBiono CGT Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 SiBiono Main Business Overview
13.14.5 SiBiono Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CGT Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. CGT Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of CAR-T Therapy
Table 4. Major Players of Viral Vector Therapy
Table 5. Major Players of Stem Cell Therapy
Table 6. Major Players of Oncolytic Virus Therapy
Table 7. Global CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global CGT Drugs Sales Market Share by Type (2017-2022)
Table 9. Global CGT Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global CGT Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global CGT Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 13. Global CGT Drugs Sales Market Share by Application (2017-2022)
Table 14. Global CGT Drugs Revenue by Application (2017-2022)
Table 15. Global CGT Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global CGT Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global CGT Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global CGT Drugs Sales Market Share by Company (2020-2022)
Table 19. Global CGT Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global CGT Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global CGT Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers CGT Drugs Producing Area Distribution and Sales Area
Table 23. Players CGT Drugs Products Offered
Table 24. CGT Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global CGT Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global CGT Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global CGT Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global CGT Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global CGT Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global CGT Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global CGT Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global CGT Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas CGT Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas CGT Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas CGT Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas CGT Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas CGT Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Americas CGT Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC CGT Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC CGT Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC CGT Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC CGT Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC CGT Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 50. APAC CGT Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe CGT Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe CGT Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe CGT Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe CGT Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe CGT Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 58. Europe CGT Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa CGT Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa CGT Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa CGT Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa CGT Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa CGT Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa CGT Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of CGT Drugs
Table 68. Key Market Challenges & Risks of CGT Drugs
Table 69. Key Industry Trends of CGT Drugs
Table 70. CGT Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. CGT Drugs Distributors List
Table 73. CGT Drugs Customer List
Table 74. Global CGT Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global CGT Drugs Sales Market Forecast by Region
Table 76. Global CGT Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global CGT Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas CGT Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas CGT Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC CGT Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC CGT Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe CGT Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe CGT Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa CGT Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa CGT Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global CGT Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global CGT Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global CGT Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global CGT Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global CGT Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global CGT Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global CGT Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global CGT Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Janssen Biotech Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Janssen Biotech CGT Drugs Product Offered
Table 96. Janssen Biotech CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Janssen Biotech Main Business
Table 98. Janssen Biotech Latest Developments
Table 99. Celgene Corporation Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Celgene Corporation CGT Drugs Product Offered
Table 101. Celgene Corporation CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Celgene Corporation Main Business
Table 103. Celgene Corporation Latest Developments
Table 104. Juno Therapeutics Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Juno Therapeutics CGT Drugs Product Offered
Table 106. Juno Therapeutics CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Juno Therapeutics Main Business
Table 108. Juno Therapeutics Latest Developments
Table 109. Kite Pharma Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Kite Pharma CGT Drugs Product Offered
Table 111. Kite Pharma CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Kite Pharma Main Business
Table 113. Kite Pharma Latest Developments
Table 114. Novartis Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis CGT Drugs Product Offered
Table 116. Novartis CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Novartis Main Business
Table 118. Novartis Latest Developments
Table 119. Spark Therapeutics Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Spark Therapeutics CGT Drugs Product Offered
Table 121. Spark Therapeutics CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Spark Therapeutics Main Business
Table 123. Spark Therapeutics Latest Developments
Table 124. Amgen Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Amgen CGT Drugs Product Offered
Table 126. Amgen CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Amgen Main Business
Table 128. Amgen Latest Developments
Table 129. Bluebird Bio Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Bluebird Bio CGT Drugs Product Offered
Table 131. Bluebird Bio CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Bluebird Bio Main Business
Table 133. Bluebird Bio Latest Developments
Table 134. GSK Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. GSK CGT Drugs Product Offered
Table 136. GSK CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. GSK Main Business
Table 138. GSK Latest Developments
Table 139. Orchard Therapeutics Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Orchard Therapeutics CGT Drugs Product Offered
Table 141. Orchard Therapeutics CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Orchard Therapeutics Main Business
Table 143. Orchard Therapeutics Latest Developments
Table 144. Sequoia Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Sequoia CGT Drugs Product Offered
Table 146. Sequoia CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Sequoia Main Business
Table 148. Sequoia Latest Developments
Table 149. Fosun Kite Biotechnology Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Fosun Kite Biotechnology CGT Drugs Product Offered
Table 151. Fosun Kite Biotechnology CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Fosun Kite Biotechnology Main Business
Table 153. Fosun Kite Biotechnology Latest Developments
Table 154. Sunway Biotech Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Sunway Biotech CGT Drugs Product Offered
Table 156. Sunway Biotech CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Sunway Biotech Main Business
Table 158. Sunway Biotech Latest Developments
Table 159. SiBiono Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. SiBiono CGT Drugs Product Offered
Table 161. SiBiono CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. SiBiono Main Business
Table 163. SiBiono Latest Developments
Table 1. CGT Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. CGT Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of CAR-T Therapy
Table 4. Major Players of Viral Vector Therapy
Table 5. Major Players of Stem Cell Therapy
Table 6. Major Players of Oncolytic Virus Therapy
Table 7. Global CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global CGT Drugs Sales Market Share by Type (2017-2022)
Table 9. Global CGT Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global CGT Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global CGT Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 13. Global CGT Drugs Sales Market Share by Application (2017-2022)
Table 14. Global CGT Drugs Revenue by Application (2017-2022)
Table 15. Global CGT Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global CGT Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global CGT Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global CGT Drugs Sales Market Share by Company (2020-2022)
Table 19. Global CGT Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global CGT Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global CGT Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers CGT Drugs Producing Area Distribution and Sales Area
Table 23. Players CGT Drugs Products Offered
Table 24. CGT Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global CGT Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global CGT Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global CGT Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global CGT Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global CGT Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global CGT Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global CGT Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global CGT Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas CGT Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas CGT Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas CGT Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas CGT Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas CGT Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Americas CGT Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC CGT Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC CGT Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC CGT Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC CGT Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC CGT Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 50. APAC CGT Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe CGT Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe CGT Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe CGT Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe CGT Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe CGT Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 58. Europe CGT Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa CGT Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa CGT Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa CGT Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa CGT Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa CGT Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa CGT Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa CGT Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa CGT Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of CGT Drugs
Table 68. Key Market Challenges & Risks of CGT Drugs
Table 69. Key Industry Trends of CGT Drugs
Table 70. CGT Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. CGT Drugs Distributors List
Table 73. CGT Drugs Customer List
Table 74. Global CGT Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global CGT Drugs Sales Market Forecast by Region
Table 76. Global CGT Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global CGT Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas CGT Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas CGT Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC CGT Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC CGT Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe CGT Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe CGT Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa CGT Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa CGT Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global CGT Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global CGT Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global CGT Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global CGT Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global CGT Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global CGT Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global CGT Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global CGT Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Janssen Biotech Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Janssen Biotech CGT Drugs Product Offered
Table 96. Janssen Biotech CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Janssen Biotech Main Business
Table 98. Janssen Biotech Latest Developments
Table 99. Celgene Corporation Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Celgene Corporation CGT Drugs Product Offered
Table 101. Celgene Corporation CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Celgene Corporation Main Business
Table 103. Celgene Corporation Latest Developments
Table 104. Juno Therapeutics Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Juno Therapeutics CGT Drugs Product Offered
Table 106. Juno Therapeutics CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Juno Therapeutics Main Business
Table 108. Juno Therapeutics Latest Developments
Table 109. Kite Pharma Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Kite Pharma CGT Drugs Product Offered
Table 111. Kite Pharma CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Kite Pharma Main Business
Table 113. Kite Pharma Latest Developments
Table 114. Novartis Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis CGT Drugs Product Offered
Table 116. Novartis CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Novartis Main Business
Table 118. Novartis Latest Developments
Table 119. Spark Therapeutics Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Spark Therapeutics CGT Drugs Product Offered
Table 121. Spark Therapeutics CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Spark Therapeutics Main Business
Table 123. Spark Therapeutics Latest Developments
Table 124. Amgen Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Amgen CGT Drugs Product Offered
Table 126. Amgen CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Amgen Main Business
Table 128. Amgen Latest Developments
Table 129. Bluebird Bio Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Bluebird Bio CGT Drugs Product Offered
Table 131. Bluebird Bio CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Bluebird Bio Main Business
Table 133. Bluebird Bio Latest Developments
Table 134. GSK Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. GSK CGT Drugs Product Offered
Table 136. GSK CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. GSK Main Business
Table 138. GSK Latest Developments
Table 139. Orchard Therapeutics Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Orchard Therapeutics CGT Drugs Product Offered
Table 141. Orchard Therapeutics CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Orchard Therapeutics Main Business
Table 143. Orchard Therapeutics Latest Developments
Table 144. Sequoia Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Sequoia CGT Drugs Product Offered
Table 146. Sequoia CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Sequoia Main Business
Table 148. Sequoia Latest Developments
Table 149. Fosun Kite Biotechnology Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Fosun Kite Biotechnology CGT Drugs Product Offered
Table 151. Fosun Kite Biotechnology CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Fosun Kite Biotechnology Main Business
Table 153. Fosun Kite Biotechnology Latest Developments
Table 154. Sunway Biotech Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Sunway Biotech CGT Drugs Product Offered
Table 156. Sunway Biotech CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Sunway Biotech Main Business
Table 158. Sunway Biotech Latest Developments
Table 159. SiBiono Basic Information, CGT Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. SiBiono CGT Drugs Product Offered
Table 161. SiBiono CGT Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. SiBiono Main Business
Table 163. SiBiono Latest Developments
LIST OF FIGURES
Figure 1. Picture of CGT Drugs
Figure 2. CGT Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CGT Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global CGT Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. CGT Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of CAR-T Therapy
Figure 10. Product Picture of Viral Vector Therapy
Figure 11. Product Picture of Stem Cell Therapy
Figure 12. Product Picture of Oncolytic Virus Therapy
Figure 13. Global CGT Drugs Sales Market Share by Type in 2021
Figure 14. Global CGT Drugs Revenue Market Share by Type (2017-2022)
Figure 15. CGT Drugs Consumed in Rare Disease
Figure 16. Global CGT Drugs Market: Rare Disease (2017-2022) & (K Units)
Figure 17. CGT Drugs Consumed in Tumor Disease
Figure 18. Global CGT Drugs Market: Tumor Disease (2017-2022) & (K Units)
Figure 19. CGT Drugs Consumed in Eye Disease
Figure 20. Global CGT Drugs Market: Eye Disease (2017-2022) & (K Units)
Figure 21. CGT Drugs Consumed in Others
Figure 22. Global CGT Drugs Market: Others (2017-2022) & (K Units)
Figure 23. Global CGT Drugs Sales Market Share by Application (2017-2022)
Figure 24. Global CGT Drugs Revenue Market Share by Application in 2021
Figure 25. CGT Drugs Revenue Market by Company in 2021 ($ Million)
Figure 26. Global CGT Drugs Revenue Market Share by Company in 2021
Figure 27. Global CGT Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global CGT Drugs Revenue Market Share by Geographic Region in 2021
Figure 29. Global CGT Drugs Sales Market Share by Region (2017-2022)
Figure 30. Global CGT Drugs Revenue Market Share by Country/Region in 2021
Figure 31. Americas CGT Drugs Sales 2017-2022 (K Units)
Figure 32. Americas CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 33. APAC CGT Drugs Sales 2017-2022 (K Units)
Figure 34. APAC CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Europe CGT Drugs Sales 2017-2022 (K Units)
Figure 36. Europe CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa CGT Drugs Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Americas CGT Drugs Sales Market Share by Country in 2021
Figure 40. Americas CGT Drugs Revenue Market Share by Country in 2021
Figure 41. United States CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC CGT Drugs Sales Market Share by Region in 2021
Figure 46. APAC CGT Drugs Revenue Market Share by Regions in 2021
Figure 47. China CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. India CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe CGT Drugs Sales Market Share by Country in 2021
Figure 54. Europe CGT Drugs Revenue Market Share by Country in 2021
Figure 55. Germany CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. France CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa CGT Drugs Sales Market Share by Country in 2021
Figure 61. Middle East & Africa CGT Drugs Revenue Market Share by Country in 2021
Figure 62. Egypt CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of CGT Drugs in 2021
Figure 68. Manufacturing Process Analysis of CGT Drugs
Figure 69. Industry Chain Structure of CGT Drugs
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 1. Picture of CGT Drugs
Figure 2. CGT Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CGT Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global CGT Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. CGT Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of CAR-T Therapy
Figure 10. Product Picture of Viral Vector Therapy
Figure 11. Product Picture of Stem Cell Therapy
Figure 12. Product Picture of Oncolytic Virus Therapy
Figure 13. Global CGT Drugs Sales Market Share by Type in 2021
Figure 14. Global CGT Drugs Revenue Market Share by Type (2017-2022)
Figure 15. CGT Drugs Consumed in Rare Disease
Figure 16. Global CGT Drugs Market: Rare Disease (2017-2022) & (K Units)
Figure 17. CGT Drugs Consumed in Tumor Disease
Figure 18. Global CGT Drugs Market: Tumor Disease (2017-2022) & (K Units)
Figure 19. CGT Drugs Consumed in Eye Disease
Figure 20. Global CGT Drugs Market: Eye Disease (2017-2022) & (K Units)
Figure 21. CGT Drugs Consumed in Others
Figure 22. Global CGT Drugs Market: Others (2017-2022) & (K Units)
Figure 23. Global CGT Drugs Sales Market Share by Application (2017-2022)
Figure 24. Global CGT Drugs Revenue Market Share by Application in 2021
Figure 25. CGT Drugs Revenue Market by Company in 2021 ($ Million)
Figure 26. Global CGT Drugs Revenue Market Share by Company in 2021
Figure 27. Global CGT Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global CGT Drugs Revenue Market Share by Geographic Region in 2021
Figure 29. Global CGT Drugs Sales Market Share by Region (2017-2022)
Figure 30. Global CGT Drugs Revenue Market Share by Country/Region in 2021
Figure 31. Americas CGT Drugs Sales 2017-2022 (K Units)
Figure 32. Americas CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 33. APAC CGT Drugs Sales 2017-2022 (K Units)
Figure 34. APAC CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Europe CGT Drugs Sales 2017-2022 (K Units)
Figure 36. Europe CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa CGT Drugs Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa CGT Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Americas CGT Drugs Sales Market Share by Country in 2021
Figure 40. Americas CGT Drugs Revenue Market Share by Country in 2021
Figure 41. United States CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC CGT Drugs Sales Market Share by Region in 2021
Figure 46. APAC CGT Drugs Revenue Market Share by Regions in 2021
Figure 47. China CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. India CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe CGT Drugs Sales Market Share by Country in 2021
Figure 54. Europe CGT Drugs Revenue Market Share by Country in 2021
Figure 55. Germany CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. France CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa CGT Drugs Sales Market Share by Country in 2021
Figure 61. Middle East & Africa CGT Drugs Revenue Market Share by Country in 2021
Figure 62. Egypt CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country CGT Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of CGT Drugs in 2021
Figure 68. Manufacturing Process Analysis of CGT Drugs
Figure 69. Industry Chain Structure of CGT Drugs
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
